Invesco’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $826K | Buy |
40,429
+8,178
| +25% | +$167K | ﹤0.01% | 2925 |
|
|
2025
Q1 | $646K | Buy |
32,251
+4,717
| +17% | +$94.4K | ﹤0.01% | 3038 |
|
|
2024
Q4 | $734K | Buy |
27,534
+616
| +2% | +$16.4K | ﹤0.01% | 3036 |
|
|
2024
Q3 | $768K | Sell |
26,918
-130
| -0.5% | -$3.71K | ﹤0.01% | 3021 |
|
|
2024
Q2 | $589K | Sell |
27,048
-348
| -1% | -$7.58K | ﹤0.01% | 3196 |
|
|
2024
Q1 | $607K | Sell |
27,396
-4,760
| -15% | -$105K | ﹤0.01% | 3221 |
|
|
2023
Q4 | $694K | Sell |
32,156
-3,801
| -11% | -$82K | ﹤0.01% | 3048 |
|
|
2023
Q3 | $607K | Buy |
35,957
+12,238
| +52% | +$207K | ﹤0.01% | 3098 |
|
|
2023
Q2 | $325K | Buy |
23,719
+814
| +4% | +$11.2K | ﹤0.01% | 3449 |
|
|
2023
Q1 | $520K | Buy |
22,905
+3,782
| +20% | +$85.9K | ﹤0.01% | 3227 |
|
|
2022
Q4 | $450K | Sell |
19,123
-326,856
| -94% | -$7.69M | ﹤0.01% | 3305 |
|
|
2022
Q3 | $9.02M | Sell |
345,979
-2,883
| -0.8% | -$75.2K | ﹤0.01% | 1864 |
|
|
2022
Q2 | $7.66M | Sell |
348,862
-730,170
| -68% | -$16M | ﹤0.01% | 2021 |
|
|
2022
Q1 | $48.4M | Buy |
1,079,032
+29,372
| +3% | +$1.32M | 0.01% | 1021 |
|
|
2021
Q4 | $45M | Buy |
1,049,660
+18,002
| +2% | +$772K | 0.01% | 1088 |
|
|
2021
Q3 | $68.6M | Sell |
1,031,658
-106,594
| -9% | -$7.09M | 0.02% | 930 |
|
|
2021
Q2 | $83.5M | Buy |
1,138,252
+111,547
| +11% | +$8.18M | 0.02% | 898 |
|
|
2021
Q1 | $70.3M | Sell |
1,026,705
-92,418
| -8% | -$6.33M | 0.02% | 927 |
|
|
2020
Q4 | $75.1M | Buy |
1,119,123
+1,035,819
| +1,243% | +$69.6M | 0.02% | 868 |
|
|
2020
Q3 | $4.29M | Buy |
83,304
+66,367
| +392% | +$3.41M | ﹤0.01% | 2074 |
|
|
2020
Q2 | $638K | Buy |
+16,937
| New | +$638K | ﹤0.01% | 3004 |
|